Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 4/2006

01-11-2006 | Original Paper

Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families

Authors: Kathleen Yang, Brian Allen, Peggy Conrad, C. Bethan Powell, Jonathan Terdiman, Lee-may Chen

Published in: Familial Cancer | Issue 4/2006

Login to get access
Metadata
Title
Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families
Authors
Kathleen Yang
Brian Allen
Peggy Conrad
C. Bethan Powell
Jonathan Terdiman
Lee-may Chen
Publication date
01-11-2006
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 4/2006
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-0012-x

Other articles of this Issue 4/2006

Familial Cancer 4/2006 Go to the issue

Original Paper

Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue

OriginalPaper

Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer

Original Paper

Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing

Editorial Notes

BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families

OriginalPaper

Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations

Original Paper

Screening behavior in women at increased familial risk for breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits